reports
AMG to Announce First-Quarter Results on May 6, 2024
AMG to Announce First-Quarter Results on May 6, 2024 Conference Call Scheduled for 8:30 a.m. Eastern Time WEST PALM BEACH, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the first quarter ended March 31, 2024 on Monday, May 6, 2024. A conference call will be held at 8:30 a.m. Eastern time on the same day. In addition to quarterly results, the conference call may include discussion of management’s expectations of future financial and operating results. Jay C. Horgen, President and Chief Executive Officer, Thomas M. Wojcik, Chief ...
Block Advisors by H&R Block Launches ‘Fund Her Future’ Grant Program t...
Block Advisors by H&R Block Launches ‘Fund Her Future’ Grant Program to Support Women-Owned Small Businesses Five winners will receive grants totaling $100,000 and access to Block Advisors services and experts to aid growth and create impact in their communities KANSAS CITY, Mo., April 29, 2024 (GLOBE NEWSWIRE) -- To help close the gap in funding and support for women-owned small businesses, by created the small business grant program. The program will award five women-owned small businesses a combined total of $100,000 in funding and access to a year of small business services from ...
Core Molding Technologies Publishes Its 2nd Annual Sustainability Repo...
Core Molding Technologies Publishes Its 2nd Annual Sustainability Report COLUMBUS, Ohio, April 29, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada, and Mexico today announced the release of its second annual Sustainability Report, which focuses on its Environmental, Social, and Governance ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RGLD ROYAL GOLD INC
URI UNITED RENTALS INC.
DOV DOVER CORPORATION
MTH MERITAGE HOMES CORPORATION
MRK MERCK & CO. INC.
FORM FORMFACTOR INC.
CPF CENTRAL PACIFIC FINANCIAL CORP.
CHDN CHURCHILL DOWNS INCORPORATED
AR ANTERO RESOURCES CORPORATION
UVSP UNIVEST FINANCIAL CORPORATION
VIRT VIRTU FINANCIAL INC. CLASS A
NOC NORTHROP GRUMMAN CORPORATION
CECE CECO ENVIRONMENTAL CORP.
CMG CHIPOTLE MEXICAN GRILL INC.
PI IMPINJ INC.
MRUS MERUS B V
ADES ADVANCED EMISSIONS SOLUTIONS
HCC WARRIOR MET COAL INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
KDP KEURIG DR PEPPER INC.
MMMB MAMAMANCINI'S HOLDINGS INC
FXI ISHARES CHINA LARGE-CAP ETF
STRA STRATEGIC EDUCATION INC.
DELL DELL TECHNOLOGIES INC CLASS C
TNK TEEKAY TANKERS
AIMD.P AIM4 VENTURES
ALXO ALX ONCOLOGY HOLDINGS
CSU CAPITAL SENIOR LIVING
LRN STRIDE INC
VRT VERTIV HOLDINGS CO (A)
AMR ALPHA METALLURGICAL RESOURCES INC
RSVR RESERVOIR MEDIA
CADL INC.
SG CANDEL THERAPEUTICS INC
EEMA SWEETGREEN INC
CASH ONTO INNOVATION INC.
FEBO ISHARES MSCI EMERGING MARKETS ASIA INDEX
METC HORIZONS HIGH INTEREST SAVINGS ETF
PROP FENBO HOLDINGS LIMITED
AESI RAMACO RESOURCES INC.
PRAIRIE OPERATING CO.
ATLAS ENERGY SOLUTIONS INC CL A
H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024
H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024 KANSAS CITY, Mo., April 25, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) will report fiscal 2024 third quarter results on Thursday, May 9, 2024, after the New York Stock Exchange market close. At that time, a copy of the press release and presentation will be available on the company's investor relations website at . A conference call for analysts, institutional investors, and shareholders will be held at 4:30 p.m. Eastern time on Thursday, May 9, 2024. During the conference call the company will discuss fi...
Merus gibt Annahme von Abstracts zur Präsentation auf der ASCO-Jahrest...
Merus gibt Annahme von Abstracts zur Präsentation auf der ASCO-Jahrestagung 2024 bekannt Petosemtamab in Kombination mit Pembrolizumab als 1L bei HNSCC – erste vorläufige klinische Daten für eine mündliche Kurzpräsentation ausgewählt MCLA-145 als Monotherapie oder in Kombination mit Pembrolizumab bei soliden Tumoren – erste vorläufige klinische Daten für eine mündliche Kurzpräsentation ausgewählt MCLA-129 bei NSCLC mit c-MET-Exon-14-Skipping-Mutationen – erste vorläufige klinische Daten für eine Posterpräsentation ausgewählt UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, April 25, 2...
Merus annonce les résumés acceptés pour présentation à la réunion annu...
Merus annonce les résumés acceptés pour présentation à la réunion annuelle 2024 de l’ASCO Pétosemtamab en association avec le pembrolizumab en traitement de première intention du carcinome épidermoïde de la tête et du cou : premières données cliniques provisoires sélectionnées pour une présentation orale rapide MCLA-145 en monothérapie ou en association avec le pembrolizumab dans les tumeurs solides : premières données cliniques provisoires sélectionnées pour une présentation orale rapide MCLA-129 dans le cancer bronchique non à petites cellules avec mutations conduisant à un saut de ...
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO A...
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data selected for rapid oral session presentation MCLA-145 as monotherapy or in combination with pembrolizumab in solid tumors initial interim clinical data selected for rapid oral session presentation MCLA-129 in NSCLC with c-MET exon 14 skipping mutations initial interim clinical data selected for poster presentation UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS) (Me...
Core Molding Technologies Announces Timing of First Quarter Fiscal Yea...
Core Molding Technologies Announces Timing of First Quarter Fiscal Year 2024 Results COLUMBUS, Ohio, April 18, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, utilities, transportation and powersports industries across North America, today announces that it will release its first quarter fiscal year 2024 results on Tuesday, May 7, 2024, before the market opens. In conjunction with the release, the Comp...
Core Molding Technologies Presented with a 2024 BRP Gold Supplier Awar...
Core Molding Technologies Presented with a 2024 BRP Gold Supplier Award Featuring BRP Sea-Doo Boat and Personal Watercraft Models COLUMBUS, Ohio, April 16, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”) announced it was presented with BRP’s Gold Supplier Award based on excellence in quality, manufacturing, and logistics related to its Sea-Doo boat and personal watercraft models. BRP awards the Gold Supplier Award to suppliers that have provided excellent customer service and technical support. The award is based o...
Greif Inc: 1 director
A director at Greif Inc bought 10,082 shares at 68.234USD and the significance rating of the trade was 92/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Canc...
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024 UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced preclinical data on zenocutuzumab (Zeno) in cancer models with high neuregulin 1 (NRG1) expression were presented at the American Association of Cancer Research (AACR) Annual Me...
Merus stellt auf der AACR-Jahrestagung 2024 präklinische Daten als Bel...
Merus stellt auf der AACR-Jahrestagung 2024 präklinische Daten als Beleg für die Wirksamkeit von Zeno in Krebsmodellen mit hoher NRG1-Expression vor UTRECHT, Niederlande, und CAMBRIDGE, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS) („Merus“, „das Unternehmen“, „wir“ oder „unser“), ein in der klinischer Phase tätiges Unternehmen im Bereich der Onkologie, das innovative multispezifische Antikörper in voller Länge (Biclonics® und Triclonics®) entwickelt, gab heute die Vorstellung von präklinischen Daten zu Zenocutuzumab (Zeno) in Krebsmodellen mit hoher Neuregulin 1 (NRG1)-Expres...
Merus présente des données précliniques démontrant l’efficacité de Zen...
Merus présente des données précliniques démontrant l’efficacité de Zeno dans le traitement des modèles de cancer avec une forte expression du gène NRG1 lors de la réunion annuelle 2024 de l’AACR UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 08 avr. 2024 (GLOBE NEWSWIRE) -- (Nasdaq : MRUS) (« Merus », la « Société », « nous » ou « notre »)/« nos », une société spécialisée dans l’oncologie au stade clinique développant des anticorps de pleine longueur multispécifiques innovants (Biclonics® et Triclonics®), a annoncé aujourd’hui que des données précliniques sur le zénocutuzumab (« Zeno ») ...
Pizza for Procrastinators: H&R Block Partners with Domino's® to Incent...
Pizza for Procrastinators: H&R Block Partners with Domino's® to Incentivize Last-Minute Tax Filers to Finish Returns by April 10 KANSAS CITY, Mo., April 05, 2024 (GLOBE NEWSWIRE) -- The number of filers that wait until April 15 to file their taxes is surprisingly high according to H&R Block and IRS data. This year, (NYSE: HRB), the company that revolutionized the tax services industry, is helping last-minute filers lower their stress level and experience the joy of completing an important task five days ahead of the filing deadline. New clients who file in-person or virtually with an H&R...
Merus nimmt an einem Kamingespräch auf der 23. jährlichen Needham Virt...
Merus nimmt an einem Kamingespräch auf der 23. jährlichen Needham Virtual Healthcare Conference teil UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, April 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS), ein im klinischen Stadium tätiges Onkologieunternehmen, das innovative multispezifische Antikörper in voller Länge (Biclonics® und Triclonics®) entwickelt, hat heute bekanntgegeben, dass Dr. Bill Lundberg, President und Chief Executive Officer von Merus, am Mittwoch, 10. April 2024, um 8:45 Uhr (Eastern Time) an einem Kamingespräch auf der 23. jährlichen Needham Virtual Healthcare Confer...
Merus participera à une discussion informelle lors de la 23e conférenc...
Merus participera à une discussion informelle lors de la 23e conférence annuelle Needham Virtual Healthcare UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 03 avr. 2024 (GLOBE NEWSWIRE) -- (Nasdaq : MRUS), une société spécialisée dans l’oncologie au stade clinique développant des anticorps de pleine longueur multispécifiques et novateurs (Biclonics® et Triclonics®), annonce ce jour la participation de Bill Lundberg, M.D., Président et directeur général de Merus, à une discussion informelle lors de la 23e conférence annuelle Needham Virtual Healthcare qui se tiendra le mercredi 10 avril 20...
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Vir...
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024 at 8:45 a.m. ET. The webcast of the presentation will be cont...
Moody's announces completion of a periodic review of ratings of WESCO ...
Moody's Ratings has completed a periodic review of the ratings of WESCO International, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 26 March 2024 in which Moody's reassessed the appropriateness of the ratings in the context...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.